Drug intelligence / Profile preview

phosphatidylserine + omega-3

Development stage
Phase 2
Lead developer
Nutribiolite
Modality
Small Molecules
Administration
Oral
01

Overview

Phosphatidylserine + omega-3 is a combination dietary supplement containing the phospholipid phosphatidylserine (PS) and omega-3 fatty acids (primarily docosahexaenoic acid [DHA] and eicosapentaenoic acid [EPA]). Both components are essential for healthy brain function. Phosphatidylserine is a key structural component of neuronal cell membranes and supports neurotransmitter release, memory formation, mood regulation, and stress response. Omega-3 fatty acids (DHA/EPA) are critical for maintaining membrane fluidity in neurons and have anti-inflammatory properties. The combination has been studied for cognitive enhancement in elderly individuals with memory complaints or mild cognitive impairment, as well as adjunctive therapy in late-life depression resistant to antidepressants[1][2][4]. It may also help reduce symptoms of ADHD in children[4][7], improve stress tolerance by modulating hypothalamic-pituitary-adrenal axis activity[2], support visual health[5], reduce muscle soreness after exercise[7], and lower cortisol levels associated with chronic stress or overtraining[1][2]. The mechanism involves synergistic effects on neuronal membrane integrity/functionality, neurotransmitter signaling (acetylcholine, dopamine), protein kinase activation related to learning/memory processes (for PS), anti-inflammatory action (for omega-3s), normalization of circadian cortisol rhythms in depression/stress states, and improved bioavailability when co-formulated due to lipid solubility requirements.

Brand names
DHA-PSBrain complex
Other names
PS-DHAphosphatidylserine and omega-3 fatty acidsPS + omega-3
02

Targets

Neuronal plasma membrane phospholipid bilayer

Beyond the preview

Go deeper on phosphatidylserine + omega-3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on phosphatidylserine + omega-3.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call